From New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research:

Mark Goldsmith photo
Mark Goldsmith photo

Mark Goldsmith’s appointment as CEO of Constellation Pharmaceuticals was announced in August 2009.